The company started in a place that near to the tourist spot Luogang Xiangxue [zh] (now in the Luogang Subdistrict, Huangpu District), thus called itself Xiangxue (Chinese: 香雪; pinyin: Xiāng xuě; Jyutping: hoeng1 syut3; lit.

Eisiti was a competitor of Wong Lo Kat which was produced by Guangzhou Pharmaceuticals and Jiaduobao.

[9] The Chinese drugmaker Xiangxue Pharmaceutical Co. Ltd is developing a cutting-edge cancer therapy with American biotech firm Athenex Inc wherein the key technology that the two sides are working on are T-cell receptor-engineered T cells (TCR-T), a cancer immunotherapy.

As of 2017, it was owned by Evergrande Group, a property developer and Alibaba Group, parent company of taobao.com, and the club was known as Guangzhou Evergrande Taobao F.C.. Xiangxue Pharmaceutical also sponsored Guangdong Mingfeng [zh], another youth football team that based Zhaoqing, Guangdong Province to play in Hong Kong First Division League, the professional league of Hong Kong S.A.R., China (across the border of the Guangdong Province) as Xiangxue Pharmaceutical for 2001–02 season.

II, the B team of Shenzhen F.C., was also played in Hong Kong as Xiangxue Eisiti in 2008–09 season.

[15] As of 31 December 2016[update],[2]: 78–81  two investment vehicles of Chen Shumei (Chinese: 陈淑梅; pinyin: Chén Shū Méi; Jyutping: can4 suk6 mui4) and Wang Yonghui (Chinese: 王永辉; pinyin: Wáng Yǒng Huī; Jyutping: wong4 wing5 fai1), owned 36.98% shares of the company as the largest shareholder.